Nicholas Lachlan Opie

Nicholas Lachlan Opie

Auto-generated profile, based on publicly available information

Nicholas Lachlan Opie

Vascular Bionics Laboratory, Department of Medicine, Royal Melbourne Hospital University of Melbourne Parkville Victoria Australia

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 February 2016 in Nature Biotechnology
Verified
Journal Article
Closed access
TOThomas J Oxley
Thomas J Oxley
NONicholas L Opie
Nicholas L Opie
SJSam John
Sam John
GRGil S Rind
Gil S Rind
SRStephen M Ronayne
Stephen M Ronayne
TOTerence J O'BRien
Terence J O'BRien

18 December 2014 in PLOS ONE
Verified
Journal Article
Open access
PDF file
LALauren N. Ayton
Lauren N. Ayton
PBPeter J. Blamey
Peter J. Blamey
RGRobyn Guymer
Robyn Guymer
CLChi Luu
Chi Luu
DNDavid A. X. Nayagam
David A. X. Nayagam
FCfor the Bionic Vision Australia Research Consortium
for the Bionic Vision Australia Research Consortium
Retinal visual prostheses (“bionic eyes”) have the potential to restore vision to blind or profoundly vision-impaired patients. The medical bionic technology used to design, manufacture and implant such prostheses is still in its relative infancy, with various technologies and surgical approaches being evaluated. We hypothesised that a suprachoroidal implant location (between the sclera and choroid of the eye) would provide significant surgical and safety benefits for patients, allowing them to maintain preoperative residual vision as well as gaining prosthetic vision input from the device. This report details the first-in-human Phase 1 trial to investigate the use of retinal implants in the suprachoroidal space in three human subjects with end-stage retinitis pigmentosa. The success of the suprachoroidal surgical approach and its associated safety benefits, coupled with twelve-month post-operative efficacy data, holds promise for the field of vision restoration. Clinicaltrials.gov NCT01603576

3 December 2018 in Nature Biomedical Engineering
Verified
Journal Article
Closed access
NONicholas L. Opie
Nicholas L. Opie
SJSam E. John
Sam E. John
GRGil S. Rind
Gil S. Rind
SRStephen M. Ronayne
Stephen M. Ronayne
YWYan T. Wong
Yan T. Wong
TOThomas J. Oxley
Thomas J. Oxley

30 May 2018 in Scientific Reports
Verified
Journal Article
Open access
PDF file
SJSam John
Sam John
NONicholas L. Opie
Nicholas L. Opie
YWYan T. Wong
Yan T. Wong
GRGil S. Rind
Gil S. Rind
SRStephen M. Ronayne
Stephen M. Ronayne
TOThomas J. Oxley
Thomas J. Oxley
Recent work has demonstrated the feasibility of minimally-invasive implantation of electrodes into a cortical blood vessel. However, the effect of the dura and blood vessel on recording signal quality is not understood and may be a critical factor impacting implementation of a closed-loop endovascular neuromodulation system. The present work compares the performance and recording signal quality of a minimally-invasive endovascular neural interface with conventional subdural and epidural interfaces. We compared bandwidth, signal-to-noise ratio, and spatial resolution of recorded cortical signals using subdural, epidural and endovascular arrays four weeks after implantation in sheep. We show that the quality of the signals (bandwidth and signal-to-noise ratio) of the endovascular neural interface is not significantly different from conventional neural sensors. However, the spatial resolution depends on the array location and the frequency of recording. We also show that there is a direct correlation between the signal-noise-ratio and classification accuracy, and that decoding accuracy is comparable between electrode arrays. These results support the consideration for use of an endovascular neural interface in a clinical trial of a novel closed-loop neuromodulation technology.

21 June 2016 in IEEE Transactions on Biomedical Engineering
Verified
Journal Article
Open access
NONicholas Lachlan Opie
Nicholas Lachlan Opie
NNNicole R. van der Nagel
Nicole R. van der Nagel
SJSam E. John
Sam E. John
KVKirstan Vessey
Kirstan Vessey
GRGil S. Rind
Gil S. Rind
TOThomas J. Oxley
Thomas J. Oxley
Objective: Recently, we reported the development of a stent-mounted electrode array (Stentrode) capable of chronically recording neural signals from within a blood vessel with high fidelity. Preliminary data suggested incorporation of the Stentrode into the blood vessel wall was associated with improved recording sensitivity. We now investigate neointimal incorporation of the Stentrode, implanted in a cohort of sheep for up to 190 days. Methods: MicroCT, obtained from the Imaging and Medical Beamline at the Australian Synchrotron, and histomorphometic techniques developed specifically for evaluation of cerebral vasculature implanted with a stent-electrode array were compared as measures to assess device incorporation and vessel patency. Results: Both micro-CT analysis and histomorphometry, revealed a strong correlation between implant duration and the number of incorporated stent struts. <;10% (26/268) of stent struts were covered in neointima in sheep implanted for <;2 weeks, increasing to >78% (191/243) between 2 and 4 weeks. Average strut-to-lumen thickness from animals implanted >12 weeks was comparable across both modalities, 339 ± 15 μm measured using micro-CT and 331 ± 19 μm (n = 292) measured histologically. There was a strong correlation between lumen areas measured using the two modalities (p <; 0.001), with no observation of vessel occlusion observed from any of the 12 animals implanted for up to 190 days. Conclusion: Micro-CT and the histomorphome-

5 July 2016 in Journal of Neural Engineering
Verified
Journal Article
Closed access
PDF file
NONicholas L Opie
Nicholas L Opie
SJSam John
Sam John
GRGil S Rind
Gil S Rind
SRStephen M Ronayne
Stephen M Ronayne
DGDavid B Grayden
David B Grayden
TOThomas J Oxley
Thomas J Oxley
Objective. Recently, we reported a minimally invasive stent-electrode array capable of recording neural signals from within a blood vessel. We now investigate the use of electrochemical impedance spectroscopy (EIS) measurements to infer changes occurring to the electrode–tissue interface from devices implanted in a cohort of sheep for up to 190 days. Approach. In a cohort of 15 sheep, endovascular stent-electrode arrays were implanted in the superior sagittal sinus overlying the motor cortex for up to 190 days. EIS was performed routinely to quantify viable electrodes for up to 91 days. An equivalent circuit model (ECM) was developed from the in vivo measurements to characterize the electrode–tissue interface changes occurring to the electrodes chronically implanted within a blood vessel. Post-mortem histological assessment of stent and electrode incorporation into the wall of the cortical vessels was compared to the electrical impedance measurements. Main results. EIS could be used to infer electrode viability and was consistent with x-ray analysis performed in vivo , and post-mortem evaluation. Viable electrodes exhibited consistent 1 kHz impedances across the 91 day measurement period, with the peak resistance frequency for the acquired data also stable over time. There was a significant change in 100 Hz phase angles, increasing from −67.8° ± 8.8° at day 0 to −43.8° ± 0.8° at day 91, which was observed to stabilize after eight days. ECM’s modeled to the data suggested this change was due to an increase in the capacitance of the electrode–tissue interface. This was supported by histological assessment with >85% of the implanted stent struts covered with neointima and incorporated into the blood vessel within two weeks. Conclusion. This work demonstrated that EIS could be used to determine the viability of electrode implanted chronically within a blood vessel. Impedance measurements alone were not observed to be a useful predictor of alterations occurring at the electrode tissue interface. However, measurement of 100 Hz phase angles was in good agreement with the capacitive changes predicted by the ECM and consistent with suggestions that this represents protein absorption on the electrode surface. 100 Hz phase angles stabilized after 8 days, consistent with histologically assessed samples. Significance. These findings demonstrate the potential application of this technology for use as a chronic neural recording system and indicate the importance of conducting EIS as a measure to identify viable electrodes and changes occurring at the electrode–tissue interface.